Accès gratuit
Numéro
Colon Rectum
Volume 10, Numéro 1, Février 2016
Recommandations pour la pratique clinique - Cancer du rectum
Page(s) 48 - 54
Section Dossier Thématique / Thematic File
DOI https://doi.org/10.1007/s11725-015-0620-4
Publié en ligne 17 décembre 2015
  • Benoist S (2007) Recommandations pour la pratique clinique: comment prendre en charge un cancer du rectum avec des métastases synchrones. Gastroenterol Clin Biol 31 Spec No 1:1S75–80, S100-2 [CrossRef] [PubMed] [Google Scholar]
  • Stillwell AP, Buettner PG, Ho YH (2010) Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 34 :797–807 [CrossRef] [PubMed] [Google Scholar]
  • Cellini C, Hunt SR, Fleshman JW, et al (2010) Stage IV rectal cancer with liver metastases: is there a benefit to resection of the primary tumor? World J Surg 34:1102–8 [CrossRef] [PubMed] [Google Scholar]
  • Scheer MG, Sloots CE, van der Wilt GJ, et al (2008) Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 19:1829–35 [CrossRef] [PubMed] [Google Scholar]
  • Cirocchi R, Trastulli S, Abraha I, et al (2012). Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev 8:CD008997 [Google Scholar]
  • Gresham G, Renouf DJ, Chan M, et al (2014). Association between palliative resection of the primary tumor and overall survival in a population-based cohort of metastatic colorectal cancer patients. Ann Surg Oncol 21:3917–23 [CrossRef] [PubMed] [Google Scholar]
  • Ishihara S, Hayama T, Yamada H, et al (2014) Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study. Ann Surg Oncol 21:2949–55 [CrossRef] [PubMed] [Google Scholar]
  • Cotte E, Villeneuve L, Passot G, et al (2015). GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study. BMC Cancer 15:1060 [CrossRef] [Google Scholar]
  • Hünerbein M, Krause M, Moesta KT, et al (2005) Palliation of malignant rectal obstruction with self-expanding metal stents. Surgery 137:42–7 [CrossRef] [PubMed] [Google Scholar]
  • Song HY, Kim JH, Kim KR, et al (2008) Malignant rectal obstruction within 5 cm of the anal verge: is there a role for expandable metallic stent placement? Gastrointest Endosc 68:713–20 [CrossRef] [PubMed] [Google Scholar]
  • Endoscopy and Cancer Committee of the French Society of Digestive Endoscopy (SFED) and the French Federation of Digestive Oncology (FFCD) (2014). Place of colorectal stents in therapeutic management of malignant large bowel obstructions. Endoscopy 46:546–52 [CrossRef] [PubMed] [Google Scholar]
  • Bensignor T, Brouquet A, Dariane C, et al (2014) Pathologic response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation. Colorectal Dis. doi: 10.1111/codi.12879. [Epub ahead of print] [Google Scholar]
  • Schrag D, Weiser MR, Goodman KA, et al (2014) Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol 32:513–8 [CrossRef] [PubMed] [Google Scholar]
  • Hasegawa J, Nishimura J, Mizushima T, et al (2014) Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer. Cancer Chemother Pharmacol 73:1079–87 [CrossRef] [PubMed] [Google Scholar]
  • Poultsides GA, Servais EL, Saltz LB, et al (2009) Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy withoutsurgery as initial treatment. J ClinOncol 27:3379–84 [CrossRef] [PubMed] [Google Scholar]
  • Chua YJ, Barbachano Y, Cunningham D, et al (2010). Neoadjuvantcapecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 11:241–8 [CrossRef] [PubMed] [Google Scholar]
  • Fernandez-Martos C, Brown G, Estevan R, et al (2014) Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial. Oncologist 19:1042–3 [CrossRef] [PubMed] [Google Scholar]
  • Tougeron D, Paillot B, Michel P (2010) Outcome of primary tumor in patients withsynchronous stage IV colon or rectal cancer: so much the same yet so different. Gastroenterol Clin Biol 2010 34:e15–6 [CrossRef] [Google Scholar]
  • Tyc-Szczepaniak D, Wyrwicz L, Kepka L, et al (2013) Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study. Ann Oncol 24:2829–34 [CrossRef] [PubMed] [Google Scholar]
  • Bosset JF, Collette L, Calais G, et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–23 [CrossRef] [PubMed] [Google Scholar]
  • Nordlinger B, Sorbye H, Glimelius B, et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007–16 [CrossRef] [PubMed] [Google Scholar]
  • Manceau G, Brouquet A, Bachet JB, et al (2013) Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases. Surgery 154:528–35 [CrossRef] [PubMed] [Google Scholar]
  • van Gijn W, Marijnen CA, Nagtegaal ID, et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575–82 [CrossRef] [PubMed] [Google Scholar]
  • Silberhumer GR, Paty PB, Temple LK, et al (2014) Simultaneous resection for rectal cancer with synchronous liver metastasisis a safe procedure. Am J Surg doi: 10.1016 [Epub ahead of print] [Google Scholar]
  • Bretagnol F, Hatwell C, Farges O, et al (2008) Benefit of laparoscopy for rectal resection in patients operated simultaneously for synchronous liver metastases: preliminary experience. Surgery 144:436–41 [CrossRef] [PubMed] [Google Scholar]
  • Hatwell C, Bretagnol F, Farges O, et al (2013) Laparoscopic resection of colorectal cancer facilitates simultaneous surgery of synchronous liver metastases. Colorectal Dis 15:e21–8 [CrossRef] [PubMed] [Google Scholar]
  • Lupinacci RM, Andraus W, De Paiva Haddad LB, et al (2014) Simultaneous laparoscopic resection of primary colorectal cancer and associated liver metastases: a systematic review. Tech Coloproctol 18:129–35 [CrossRef] [PubMed] [Google Scholar]
  • Reddy SK, Pawlik TM, Zorzi D, et al (2007) Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 14:3481–91 [CrossRef] [PubMed] [Google Scholar]
  • de Haas RJ, Adam R, Wicherts DA, et al (2010) Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg 97:1279–89 [CrossRef] [PubMed] [Google Scholar]
  • Zalinski S, Mariette C, Farges O et al (2011) Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version. J ViscSurg 148:e171–82 [Google Scholar]
  • Karoui M, Vigano L, Goyer P, et al (2010) Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg 97:1354–62 [CrossRef] [PubMed] [Google Scholar]
  • Mentha G, Majno PE, Andres A, et al (2006) Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg. 93:872–8 [CrossRef] [PubMed] [Google Scholar]
  • Kopetz S, Chang GJ, Overman MJ, et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677–83 [CrossRef] [PubMed] [Google Scholar]
  • van der Pool AE, de Wilt JH, Lalmahomed ZS, et al (2010) Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg 97:383–90 [CrossRef] [PubMed] [Google Scholar]
  • Brouquet A, Mortenson MM, Vauthey JN, et al (2010) Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210:934–41 [CrossRef] [PubMed] [Google Scholar]
  • Andres A, Toso C, Adam R, et al (2012). A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg 256:772–8 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.